Effect of Co-trimoxazole vs Placebo Among Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis
This randomized clinical trial compares the effects of co-trimoxazole (trimethoprim-sulfamethoxazole [TMP-SMX]) vs placebo on time to death, lung transplant, or hospital admission in patients with moderate or severe idiopathic pulmonary fibrosis (IPF).
Source: JAMA - Category: General Medicine Source Type: research
More News: Bactrim | Clinical Trials | General Medicine | Hospitals | Lung Transplant | Sulfamethoxazole | Transplant Surgery | Transplants | Trimethoprim